Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Baxter
Harvard Business School
McKesson
Moodys

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089096

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 089096 describes URECHOLINE, which is a drug marketed by Odyssey Pharms and is included in five NDAs. It is available from three suppliers. Additional details are available on the URECHOLINE profile page.

The generic ingredient in URECHOLINE is bethanechol chloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
Summary for 089096
Tradename:URECHOLINE
Applicant:Odyssey Pharms
Ingredient:bethanechol chloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 089096
Medical Subject Heading (MeSH) Categories for 089096
Suppliers and Packaging for NDA: 089096
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
URECHOLINE bethanechol chloride TABLET;ORAL 089096 ANDA Teva Pharmaceuticals USA, Inc. 50111-326 50111-326-01 100 TABLET in 1 BOTTLE (50111-326-01)
URECHOLINE bethanechol chloride TABLET;ORAL 089096 ANDA Teva Women's Health, Inc. 51285-692 51285-692-02 100 TABLET in 1 BOTTLE (51285-692-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Dec 19, 1985TE:AARLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Harvard Business School
Baxter
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.